Richard B. Gaynor will retire as Senior Vice President, Global Development and Medical Affairs, Lilly Oncology as of January 2017. Prior to joining Lilly, Dr. Gaynor was a professor of medicine and microbiology at the University of Texas Southwestern Medical Center in Dallas, US. Editor note: See the interview with Dr. Gaynor on page 8.
Sign up for news updates
Richard B. Gaynor, MD
|
|
Estimated Read Time:
1–2 minutes
Share this Article:
Recent Posts
-
August 11, 2026
-
August 11, 2026
-
August 11, 2026
-
August 11, 2026
View ILCN Archives
Provider Resources
Popular Articles
-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care